Basic Information
| LncRNA/CircRNA Name | DRAIC |
| Synonyms | NA |
| Region | GRCh38_15:69463026-69843120 |
| Ensemble | ENSG00000245750 |
| Refseq | NR_026979 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | qPCR, Western blot, RIP etc. |
| Sample | GC tissues and corresponding paracancerous normal control (NC) tissues cell lines(HGC-27, SGC-7901, BGC-823, AGS, MKN45, GES-1) |
| Expression Pattern | down-regulated |
| Function Description | DRAIC is down-regulated in GC tissues and cell lines.Lower DRAIC and higher UCHL5 and NFRKB indicated advanced progression of GC patients. |
| Pubmed ID | 32351584 |
| Year | 2020 |
| Title | LncRNA DRAIC inhibits proliferation and metastasis of gastric cancer cells through interfering with NFRKB deubiquitination mediated by UCHL5. |
External Links
| Links for DRAIC | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |